DPP-4 Inhibitors, also known as dipeptidyl peptidase-4 inhibitors, form a class of oral medications used in managing Type 2 diabetes, including drugs like Sitagliptin and Saxagliptin.
Drug Family and Names:
- Sitagliptin: An oral medication commonly prescribed as a DPP-4 Inhibitor.
- Saxagliptin: Another medication in the DPP-4 Inhibitor class used for diabetes management.
Mechanism of Action:
DPP-4 Inhibitors work by slowing the breakdown of incretin hormones, which help stimulate insulin release and reduce glucose production from the liver, resulting in lowered blood sugar levels.
Indications:
Sitagliptin and Saxagliptin are prescribed:
- To improve blood sugar control in individuals with Type 2 diabetes.
- Often used in combination with other diabetes medications or as an add-on therapy to diet and exercise.
Side Effects:
Common side effects of DPP-4 Inhibitors include:
- Upper respiratory tract infections
- Headache
- Mild gastrointestinal discomfort (nausea, diarrhea)
Dosage:
Dosage varies depending on the specific medication and may range from once-daily to twice-daily dosing. It’s often prescribed in standard tablet form.
Route of Administration:
DPP-4 Inhibitors like Sitagliptin and Saxagliptin are taken orally, typically with or without food, as directed by a healthcare professional.
Precautions and Considerations:
- These medications are generally well-tolerated, but caution is advised in individuals with kidney problems.
- They have a low risk of causing hypoglycemia when used alone but can potentiate the effect of other diabetes medications.
Sitagliptin and Saxagliptin, as DPP-4 Inhibitors, offer a mechanism to enhance insulin production and suppress excess glucose release in Type 2 diabetes. They are often favored due to their convenient dosing and minimal risk of hypoglycemia.